<DOC>
	<DOCNO>NCT00053547</DOCNO>
	<brief_summary>The purpose study see Zemplar , vitamin D medication , safely effectively decrease parathyroid hormone child age 2-20 End Stage Renal Disease .</brief_summary>
	<brief_title>Safety Effectiveness Zemplar Injection Decreasing iPTH Levels Pediatric ESRD Subjects Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<criteria>Subjects age 220 ESRD hemodialysis Secondary hyperparathyroidism</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>